
NBC News @NBCNews
While many pharmacists across the U.S. have struggled to get their hands on Ozempic, some haven’t bothered, and they say it's because they're losing money on the expensive — and popular — drug. https://t.co/WoOqUs52Mf — PolitiTweet.org